|
Bone metabolism biomarkers in 3 stages of the study (n = 15). |
||||
| Variables* |
At the start |
6 weeks |
12 weeks |
P value† |
|
|
||||
| TALP (IU/l) |
237.5 ± 85.4** |
300.4 ± 294.1 |
281.3 ± 80.5 |
<0.05 |
| OC (ng/ml) |
11.4 ± 4.8 |
12.7 ± 5.7 |
11.5 ± 4.8 |
NS†† |
| IGFBP3 (ng/ml) |
3304.6 ± 728.6 |
3221.6 ± 534.4 |
3103.9 ± 639.8 |
NS |
| DPD (nmol/mmol) |
7 ± 1.2 |
5.9 ± 1.1 |
5.1 ± 2.1 |
<0.05 |
| C-TX (ng/ml) |
0.79 ± 0.49 |
0.8 ± 0.4 |
0.8 ± 0.3 |
NS |
| ITCP (μg/l) |
4.6 ± 0.9 |
4.3 ± 0.9 |
5.9 ± 1.1 |
NS |
|
* TALP: Total alkaline phosphatase (IU/l); OC: Osteocalcin (ng/ml); IGFBP3: Insulin like growth factor binding protein 3 (ng/ml); DPD: Deoxypyridinoline (nmol/mmol); C-TX: C-Telopeptides (ng/ml); ITCP: Carboxy terminal telopeptides of type I collagen (μg/l) ** Mean ± SD † To analyze changes in 3 stages, repeated measurement analysis was utilized. †† significant level was set at below 5 percent (P < 0.05). | ||||
Haghighian Roudsari et al. Nutrition Journal 2005 4:30 doi:10.1186/1475-2891-4-30 |
||||